Patent · US Active

CRISPR enzymes and systems

US12110490B2 · kind B2 · utility

3Cited by
9References
33Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 16, 2016
Grant dateOct 8, 2024
Priority date
Expiry dateNov 17, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/20
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered DNA or RNA-targeting systems comprising a novel DNA or RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.